Please provide your email address to receive an email when new articles are posted on . A pediatric typhoid vaccine provided immunity for up to 3 years in children as young as 9 months old, according ...
A new vaccine against salmonella and typhoid moves closer to approval, according to results of a clinical trial published by researchers at the University of Maryland School of Medicine Oct. 8. “These ...
Researchers have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella.
A novel trivalent vaccine targeting typhoid fever and invasive non-typhoidal Salmonella (iNTS) infections has demonstrated promising safety and robust immune responses in a Phase 1 human trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback